Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2025-12-24 @ 5:50 PM
NCT ID:
NCT05645068
Eligibility Criteria:
Inclusion Criteria:
* Patient for whom a 3-week multidisciplinary and integrative program was offered in a diabetology unit
* Patient having given his consent
* Patient affiliated to a social security scheme or equivalent
* Patient with type 2 diabetes
Exclusion Criteria:
* History of exudative or tractional retinal detachment
* Intraocular foreign body
* History of endophthalmitis
* History of inflammatory disease of the retina
* History of chorioretinitis
* Patient with age-related macular degeneration
* Patients with type 1 diabetes or secondary diabetes
* Uncontrolled hypertension does not define Systolic arterial pressure (SAP) \> 180 mmHg or Diastolic arterial pressure (DAP) \> 110 mmHg
* Patient who has already received intravitreal injections of anti-angiogenic molecules.
* Pregnant or breastfeeding patient at the time of the study
* Persons under a legal protection regime for adults (safeguard of justice, guardianship, curatorship, institutionalized, or under mandate for future protection)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05645068
Study Brief:
Protocol Section:
NCT05645068